{"name":"Dynavax Technologies Corporation","slug":"dynavax-technologies-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"HEPLISAV","genericName":"HEPLISAV","slug":"heplisav","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"HEPLISAV","genericName":"HEPLISAV","slug":"heplisav","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOVjQ4dGUtTFdVTWRCc2c2T3UzZW1BcUVlaWhuZ0poamNEX2stbGhoZzB5cWUyemVFLUVISXV1UXh3bHhqWmtiQjJNVF9QaloxbzlIaUlXSmJfUHlIWS00cEtQWWZvUmFDaWY0UndtN2VLaVVNOGlsb2x1QU9FdTlqSkE1WFNuc0dOV3o1N0p3M0NuZFVOQTNlVFR4YUVPQQ?oc=5","date":"2026-02-19","type":"pipeline","source":"BioWorld News","summary":"M&A activity drives infectious disease stock rebound - BioWorld News","headline":"M&A activity drives infectious disease stock rebound","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNZWRSbnZhYnlTWnpnYUEtVWxFa00tRXFyMEE1UmFGUmFjSDEzNnUyX0NDc29jMVE5Vm5FdDlnNGE4NnNoUVFrTVNxTHBhX1prbUNhckdkeGJiRGJoTUZKZ3B4bkoyZ3dTTlVTNGQ0ZjdtLTkybklyUjljX3FiNWQwLVlFZVFuQ2NJS3hjUWc5NWFYOTlQQi11UkdHQkFwXzRRNlplVlVWWFNTQVAtbE4ycVg0dG9zdE9ZR3FBLQ?oc=5","date":"2025-12-29","type":"deal","source":"Fierce Pharma","summary":"Acquisitive Sanofi keeps deals coming, laying out $2.2B for hepatitis vaccine maker Dynavax - Fierce Pharma","headline":"Acquisitive Sanofi keeps deals coming, laying out $2.2B for hepatitis vaccine maker Dynavax","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE5tb1BwcVNIVkZncXVGNU8zX1JDWjlmOEtnR3llNlFxNGcxU00xcEFmdERJR0xDQWluZHRPNjBMRGVibWtPWFZGRWJWVWhJaGRNRjJlR2tqUGRGT0NMMDN0QnpwTENfdDdmanNGbUdfVQ?oc=5","date":"2025-12-29","type":"deal","source":"medwatch.com","summary":"Sanofi acquires vaccine company for over USD 2 billion - medwatch.com","headline":"Sanofi acquires vaccine company for over USD 2 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQZ1BfUTVMbEswQjNqQ1BvQURVX09jaUxqM1g3bXVZVmFkMFNKenA4c2l4alpuQUQtZTQ4QUxqc05yd2hzMmsza0hucmlXelFQYXZQa00tX29GeVlvN0JQcUJYVXVwbXpIRXJMRmNlRnVGQnhrSzFvUlV5R2VUS09zc3J3T05rU0lVOHNzTFFfNEtGYmg1aFNmNmtVZEY4M2FIUU11RjVkSzJ0U3ByWEtxSmYxSjRvanc?oc=5","date":"2025-12-24","type":"deal","source":"Reuters","summary":"Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal - Reuters","headline":"Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOQnJheUUxd3lVS0RKR09nTWN6alZUeFhFcVhnMXRjZ19YRHo3cHVRT2ZuYW9VTmtxWHE5ajFaVFItOHVjMldhQlpSdDFhSFlrelg5dVJ3Y0dZeGxWaU80UHZJRHN5b2F0OFU2NlR4dlJQTG5nWVFTVnQ2bndEOWVKM3lDR0hxbG9YRGVmOVVSVXRQLUk5TElF0gFWQVVfeXFMT2ZQbjg3VlQwbTVadmx0YzdUbll6ZEpsdjFmSGtZU2V3bDRIU3FTVkt0djJMTjZkajJWUTFWd1F1YVQxb25ObFhqUEtaNTIweDBFZk5pNHc?oc=5","date":"2025-12-24","type":"deal","source":"Law360","summary":"Sanofi Buys Hepatitis Vaccine Maker Dynavax For $2.2B - Law360","headline":"Sanofi Buys Hepatitis Vaccine Maker Dynavax For $2.2B - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPVlVoTUtsV1J3eHRYSmpaVVFMQlc5bFpnMVE4ZkM0QVBLQkpKMXNLWFpndUlORG1CdE5KUElMZW40Y3dRRTRqU09HREZ1Rld5dmlIRU0xTDB0WFBvZThvRzJfc1VUQ0k3SFNFNXpYdWZjWFpUcERpM05WU3pTMGNtUGhuR0xLeTc4ekRN?oc=5","date":"2025-12-24","type":"deal","source":"The Pharma Letter","summary":"Sanofi to acquire vaccine maker Dynavax - The Pharma Letter","headline":"Sanofi to acquire vaccine maker Dynavax","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-24","type":"deal","source":"Medical Dialogues","summary":"Sanofi to acquire vaccine maker Dynavax for USD 2.2 billion - Medical Dialogues","headline":"Sanofi to acquire vaccine maker Dynavax for USD 2.2 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQZG9LaVhPV2VJdHRXcnhOS0stRzd0cDRzM3BWbUpIaGZOMHFRS2tXLUJFdGQ4QmRfMGwzaXpxY011OVNhYi1yR0FFN1VOY1piSlJJY0dNb0xtazE2eFRzREpzaml4VlhBVUN4ZFpQWmVid2VOSGxDYUJyRk5iLVVmdnhnb9IBiAFBVV95cUxNX3M4aTkzSFVBUWdPOGd1elBfc3BrZ2FrOFNHS0YzS29pYTFMTlVGT2FCTTRXeGppUFI3RjRtbU1oVDlJbk9uQk9OekxDY0N6aFdsTDRxR2NnUWRNaVBNelpRV2JqNV8zTHZlczNMNTdwdkdXUlRnV19TaVpvb2U3cldKR25PLUF2?oc=5","date":"2025-12-24","type":"deal","source":"Diari ARA","summary":"Sanofi will buy Dynavax for €1.867 billion - Diari ARA","headline":"Sanofi will buy Dynavax for €1.867 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPc3JsWDNZQkRwNF9GelZlcnc5NUlXejMwd2tsRFlGT0ZEZ2lYVlY2SHF5RnBOZ0Vvd0VNZ3drdUpNWnpod0trVHBwZTgzREIzc1FKVXJJM0hIaXctRlJaRHZCS1hsRVlXbnpuUmw0T0F5eU9UeURIdmNTYUtNLXZxbVlhTmYxcVF1VzNnUGV0bFBCZkdXMUE?oc=5","date":"2025-09-02","type":"earnings","source":"Yahoo Finance","summary":"Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook - Yahoo Finance","headline":"Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxObEpVaHRhQ2QtbE5GMENoaWl1blprVWZPWUNoOXF0RGlfY1ZrOTJLcXpNX25kWFRDUktfb002a1JIOUk4cU8zV09oZXdnMF9DOG1UU3pEYkdxazk5eE50dU5Od0VjaXVvNlNrVkZVUS1qU2RvdDJVMklTVXN1bmpfcWUyazExdG8?oc=5","date":"2025-07-06","type":"deal","source":"Yahoo Finance","summary":"Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31 - Yahoo Finance","headline":"Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOQkduWHZPeVVNSnpvRVFRWlZoX1ZXVk9lWl9Ud2tvQnk2ZWdNalNxRUI3REtSTFJwOHVCT1M5OWZWcDFSaE9sOWZTTnJva3J5cmlyRGpFMVh1Rl9DRmpoX0tJWFZjcnhub2lmWl8tT2lFZHNINXZvaEcxVDZXSDdSd2hNWHQtVXVIVFdnRHhEd2pIckwyajE1TXowNVA4QzdsTlB1QTk5TnNfVjFIeFhZeHZMc1FsRkctXzUza1FockUwU2d0RDhRc0FGVk5ZME4yVlB5eEt2ZVpoUVMzWXUzbDh5OHBrdw?oc=5","date":"2025-06-23","type":"pipeline","source":"Business Wire","summary":"Pharma & Vaccine Industry Leader Eddie Gray joins Botanical Solution Inc. (BSI) Board of Directors - Business Wire","headline":"Pharma & Vaccine Industry Leader Eddie Gray joins Botanical Solution Inc. (BSI) Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPMHB6bFk5a3oxNE1FTjdRQVl4XzRBZHNFWF9aVzlfVTRjUjNEVmMyd3o3bFA2aWt0WDhiRHREWFVOcDZpcC1iWmJQVVdWclJlbkZLYkpjZU56S2hENXVOcjlYb3FQdHpjamV1Z0pZcGxNZTg4aDBmekFodW5GdXRVNEExUTBpSF9fMFVEWGZOQWlRdmtaRV9TT21ob29OVm5WcE4yU0psTXEyLTJ0am00YjF0ZFBYMHp1dnltUlh5Z1d3MU5mVUQtdHhmb05JQUw2YTFv?oc=5","date":"2025-06-12","type":"pipeline","source":"Reuters","summary":"Dynavax elects all four of its nominees after Deep Track proxy fight - Reuters","headline":"Dynavax elects all four of its nominees after Deep Track proxy fight","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}